| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |